Emerging therapeutic approaches to treat dyslipidemia.

  title={Emerging therapeutic approaches to treat dyslipidemia.},
  author={David J Preiss and Chris J. Packard},
  journal={Current cardiology reports},
  volume={16 7},
Statins are safe, efficacious and the cornerstone of cardiovascular disease prevention strategies. A number of add-on therapies with complementary actions on the plasma lipid profile have been tested in large scale trials to see if they give incremental benefit. In particular, the 'HDL hypothesis' - that raising this lipoprotein will promote reverse cholesterol transport and reduce cardiovascular risk - has been examined using drugs such as dalcetrapib and niacin. So far, results have been… CONTINUE READING